NDAORALTABLET
Approved
Dec 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ORETICYL 25 is a fixed-dose combination tablet containing deserpidine (an alkaloid antihypertensive) and hydrochlorothiazide (a thiazide diuretic), approved in 1959 for oral management of hypertension. This dual-agent formulation targets blood pressure reduction through complementary mechanisms: deserpidine depletes catecholamine stores while hydrochlorothiazide promotes sodium and water excretion. The product represents a vintage antihypertensive therapy now in advanced stages of market maturity.
LOE Approaching
This product faces imminent loss of exclusivity with minimal current linked job postings, signaling a contracted team focused on legacy management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ORETICYL 25 offers limited career growth potential given zero linked job postings and LOE-approaching lifecycle status. Roles supporting this product are typically focused on inventory management, regulatory compliance, and customer retention rather than strategic brand building or innovation.
Brand ManagerField Sales Representative
Worked on ORETICYL 25 at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.